Evidence map›Paper›PMID 38073732›Full record

ArticleAdvanced biomedical research2023

An Observational Study of Factors affecting CA125 Levels in Premenopausal Women.

Amrita Balachandran, S Radhakrishna Nayak

Abstract read
In one paragraph

Article in Advanced biomedical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amrita BalachandranDepartment of Obstetrics and Gynecology, Kasturba Medical College, Mangalore, Karnataka, India.
S Radhakrishna NayakDepartment of Obstetrics and Gynecology, Kasturba Medical College, Mangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CA125 levels show a variation in premenopausal women during the menstrual cycle. Moreover, various modifiable and non-modifiable factors affect its value which needs to be taken into account while interpreting the results. The study was done with an objective (1) to determine differences in CA125 levels during the mid-cycle and menstrual phase of menstruation and (2) to determine the factors (demographic and clinical) that may affect CA125 values. Materials and Methods: An observational study was conducted from December 2017 to May 2019. Women of reproductive age group of 15-45 years with regular menstrual cycles were included in the study. The CA125 levels were compared among mid-cycle values and values during menstruation. A mean of the values was taken, and factors affecting it were determined by regression analysis. Results: The mean age of the patients was 28.71 ± 6.14 years. The median day of sample collection during menses was day 2 and during mid-cycle was day 14. Compared to mid-cycle CA125 values, values during menses were significantly higher (24.74 ± 17.43 vs. 12.39 ± 7.3, Conclusion: In conclusion, CA125 levels are significantly higher during menstruation as compared to mid-cycle values in premenopausal women. The significant factors leading to higher CA125 levels are days of menses and caffeine consumption.

Indexed as

CA125 antigenCaffeineMenopauseMenstruationRisk factors

Identifiers

PMID38073732
PMCPMC10699238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.